Mazzei M, Garzoglio R, Balbi A, Grandi T, De Montis A, Corrias S, La Colla P
Istituto di Scienze Farmaceutiche, Università di Genova, Italy.
Farmaco. 1996 May;51(5):351-9.
Previous studies showed that some 2'-alkyloxyisoxazoles 2b-d obtained from 3-(diethylamino)-5-(2'hydroxy-4'-methoxyphenyl)isoxazole 2a were endowed with an interesting anti-group B rhinovirus activity (action on HRV-2 serotype). Other isoxazoles (WIN compounds) are well known to have anti-group A rhinovirus activity (action on HRV-14 serotype). To obtain an action similar to that of WIN compounds, starting from 2a, the 2'-acyl (3,4,5) and 2'alkyl (6,8) derivatives were synthesized. Also some Mannich bases (9,10) and bisisoxazoles (7,11,13,14) were studied. Though some of the tested compounds mainly exhibited anti-group B rhinovirus activity, their potency was less intense with respect to the above mentioned compounds 2b-d. The only N-methylpiperazinomethyl derivative 10 was slightly active against both tested serotypes.
先前的研究表明,从3-(二乙氨基)-5-(2'-羟基-4'-甲氧基苯基)异恶唑2a制得的一些2'-烷氧基异恶唑2b-d具有有趣的抗B组鼻病毒活性(对HRV-2血清型起作用)。众所周知,其他异恶唑(WIN化合物)具有抗A组鼻病毒活性(对HRV-14血清型起作用)。为了获得与WIN化合物类似的活性,从2a出发,合成了2'-酰基(3,4,5)和2'-烷基(6,8)衍生物。还研究了一些曼尼希碱(9,10)和双异恶唑(7,11,13,14)。尽管一些测试化合物主要表现出抗B组鼻病毒活性,但相对于上述化合物2b-d,它们的效力较弱。唯一的N-甲基哌嗪甲基衍生物10对两种测试血清型均有轻微活性。